Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Non-Current Debt (2016 - 2025)

Fresenius Medical Care AG has reported Non-Current Debt over the past 17 years, most recently at $6.6 billion for Q4 2025.

  • Quarterly results put Non-Current Debt at $6.6 billion for Q4 2025, up 1051.0% from a year ago — trailing twelve months through Dec 2025 was $6.6 billion (up 1051.0% YoY), and the annual figure for FY2025 was $6.6 billion, up 1051.0%.
  • Non-Current Debt for Q4 2025 was $6.6 billion at Fresenius Medical Care AG, up from $575.6 million in the prior quarter.
  • Over the last five years, Non-Current Debt for FMCQF hit a ceiling of $7.6 billion in Q4 2021 and a floor of $575.6 million in Q4 2024.
  • Median Non-Current Debt over the past 5 years was $7.3 billion (2022), compared with a mean of $5.9 billion.
  • Biggest five-year swings in Non-Current Debt: tumbled 92.31% in 2024 and later surged 1051.0% in 2025.
  • Fresenius Medical Care AG's Non-Current Debt stood at $7.6 billion in 2021, then decreased by 3.79% to $7.3 billion in 2022, then increased by 2.36% to $7.5 billion in 2023, then tumbled by 92.31% to $575.6 million in 2024, then surged by 1051.0% to $6.6 billion in 2025.
  • The last three reported values for Non-Current Debt were $6.6 billion (Q4 2025), $575.6 million (Q4 2024), and $7.5 billion (Q4 2023) per Business Quant data.